Webinar Date & Time
14 October 2026 from 11:00 AM to 12:30 PM (CEST)
Webinar Overview
On 16 December 2025, the European Commission proposed the EU Biotech Act, a package of measures designed to improve public health while strengthening the resilience and competitiveness of the European life sciences sector. The proposals include significant amendments to Regulation (EU) No 536/2014 (EU CTR), with the aim to making the EU faster and more competitive for clinical trials conduct. Several of the proposals aim to reduce clinical trial review timelines and make the review process more efficient and some of these have been explored through the FAST-EU pilot project during 2026.
This session will examine how the FAST-EU pilot has tested some key elements of these proposed changes and considers how the lessons learned may shape the future clinical trials regulatory landscape. Participants will gain insights into emerging regulatory developments, potential impact on sponsors and investigators, and the practical implications for clinical trial planning, approval and conduct within the EU.
Presenters
Zubin Thacker
Director of Regulatory Affairs
IQVIA
Zubin has over 20 years’ experience in the pharmaceutical industry. He leads implementation of business strategy on a global/regional basis, ensures compliance of regulatory processes, training and managing regulatory professionals and supports systems development to meet Regulatory requirements. Zubin is an industry representative member for ACRO on the EMA ACT EU Advisory Group. Zubin represents IQVIA at Trade Association meetings and provides consulting for upcoming regulations as a trusted advisor to IQVIA and Regulators.
Thomas Fairman
Clinical Trials Regulatory Manager
IQVIA
Thomas Fairman is a Clinical Trials Regulatory Manager (CTRM) at IQVIA, specialising in the practical implementation of the EU Clinical Trials Regulation (CTR). With over 15 years of experience spanning the pharmaceutical industry, the NHS, and UK regulatory authorities, he brings a broad and practical perspective to clinical trial regulation and compliance. Thomas works closely with sponsors to navigate complex regulatory requirements, combining regulatory expertise with a pragmatic approach to trial delivery. Known for his professionalism and reliability, Thomas proactively addresses regulatory challenges while remaining attuned to evolving legislation, guidance, and industry trends. His strategic insight helps sponsors achieve ongoing regulatory compliance, support cross functional teams and sustain operational readiness, ensuring efficient and compliant trial execution in an increasingly complex regulatory environment.
Attendance Fee
€ 90,- for non-EUCROF members
€ 60,- for EUCROF members
Deadline for registration
13 October 2026 at 6 p.m. CEST
How to register?
1) Go on the REGISTRATION PAGE and click on the orange button “GET TICKETS”
2) Check your order and click on the green “CHECKOUT” button
3) Fill in all the necessary information and validate your order
Confirmation
You will receive 2 confirmation emails:
A) One from Eventbrite with your invoice
B) One from “Eucrof” with all the necessary information to connect the D-Day!
Questions?
Should you have any questions about registration, invoices or connection, do not hesitate and contact us by email at webinar@eucrof.eu
By registering to the webinar, you give your authorisation to the webinar organizers to use your email address and personal information to communicate with you about this event and future initiatives. To stop receiving their communications, please contact the organizers directly at info@eucrof.eu.
